PlainRecalls
FDA Drug Low Class III Ongoing

Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.

Reported: December 24, 2025 Initiated: November 26, 2025 #D-0236-2026

Product Description

Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.

Reason for Recall

Subpotent product:out of specification assay results observed during long term stability testing.

Details

Recalling Firm
SOMERSET THERAPEUTICS LLC
Units Affected
52,340 5mL vials
Distribution
Nationwide in the USA
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.. Recalled by SOMERSET THERAPEUTICS LLC. Units affected: 52,340 5mL vials.
Why was this product recalled?
Subpotent product:out of specification assay results observed during long term stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 24, 2025. Severity: Low. Recall number: D-0236-2026.